Skip to content

Oncurious

Active
Public limited companyfounded 201511 yrs activeWerkhuizenkaai 160, 1000 Brussel, BelgiumKBO/BCE: BE 0627.952.462
Summary

Oncurious has been active since 2015 and the Belgian State Gazette contains no insolvency signals. The CBE does carry 1 administrative register entry (see administrative flags). The 2024 annual accounts show equity of €96,543 and a net result of -€27,977. Equity is shrinking by ~22.5% per year across the filed fiscal years. Its solvency ranks better than 30% of 2159 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.4% (very low).

Checked score

Score 2024
Axes · tick = 2023
Profitability9▼-18
Solvency65▲+3
Growth58=
Track record92
Bankruptcy probability, 12 months
0.4% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €6,000 at 30 days acceptable
Liquidity ample (current ratio 11.29; short-term debt: 8.9% and cash: 34% of total assets), but 60.3% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Ten signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies more bankruptcies →
raises risk · Recent warning signals
The last 24 months brought warning signals in the Staatsblad or the KBO, and those often pile up before a bankruptcy.
Belgian State Gazette
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2024
Solvency, return and age of the figures
Solvency
39.7%
Return on assets
-11.5%
Age of the figures
21 mo
raises risk · Ex-officio strike-off
The KBO struck this company off ex officio, which points to unmet obligations and often precedes a bankruptcy.
KBO publications
lowers risk · Lower-risk legal form
Companies with this legal form statistically fail less often than a BV.
KBO · legal form
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 11 years 0 20 y
raises risk · Persistent losses
Two consecutive loss-making years (2023 and 2024); equity is also lower. May indicate structural pressure on profitability.
NBB · annual accounts 2024
Net result per financial year
18192021222324
2018 to 2024 · latest year -€27,977
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 27-06-2025, 34 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
not confirmed
2024
34 d early
2023
43 d early
2022
18 d late
2021
39 d late
2020
61 d late
2019
65 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 6 accounts on average 4 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.

raises risk · Administrative warnings in the KBO publications
1 publication by the FPS Economy about this company, such as a strike-off for address, accounts or UBO, or its withdrawal.
KBO publications
Publications
Address struck

History

Oncurious was incorporated on 3 April 2015.1 The registered office was moved to Brussel in 2026.2 Since 2026, TROESCH Jonas has served as director of the company.2 Total assets fell from EUR 3.4 million in 2018 to EUR 243,269 in 2024 and headcount from 2.1 full-time equivalents in 2018 to 5.6 in 2021.3

  1. 1Crossroads Bank for Enterprises
  2. 2Belgian State Gazette, 04-09-2026
  3. 3National Bank, annual accounts 2018, 2021 and 2024

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2024, abbreviated schema

Equity
€96,543▼ 22.5%
2023 · €124,520
Total assets
€243,269▼ 28.1%
2023 · €338,369
Net result
-€27,977▼ 104%
2023 · -€13,718
Working capital
€221,716▼ 34.3%
2023 · €337,649
Trend over the years
In euros
In per cent
Ratio
In full-time equivalents (FTE)
In euros
No line ticked in this group.
In per cent
No line ticked in this group.
Ratio
No line ticked in this group.
In full-time equivalents (FTE)
No line ticked in this group.

Untick a line to hide it. Point at a year (or use the arrow keys on the chart) for the exact figures; the table below gives them all.Sector: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA), Staff (FTE).

Every figure with its change against the fiscal year before
favourable unfavourable
Line20202021202220232024
Operating result-€4.6m▼ 191%-€2.9m▲ 36.5%-€46,985▲ 98.4%-€6,397▲ 86.4%-€20,722▼ 224%
Net result-€4.5mbelow the sector's middle half▼ 200%-€2.9mbelow the sector's middle half▲ 36.4%-€47,942below the sector's middle half▲ 98.3%-€13,718below the sector's middle half▲ 71.4%-€27,977below the sector's middle half▼ 104%
Equity€2.0mabove the sector's middle half▲ 639%€186,180within the sector's middle half▼ 90.8%€138,237below the sector's middle half▼ 25.8%€124,520below the sector's middle half▼ 9.9%€96,543below the sector's middle half▼ 22.5%
Total assets€2.7mabove the sector's middle half▼ 42.7%€468,931within the sector's middle half▼ 82.4%€484,062within the sector's middle half▲ 3.2%€338,369below the sector's middle half▼ 30.1%€243,269below the sector's middle half▼ 28.1%
Debt€642,398▼ 85.3%€282,752▼ 56.0%€345,825▲ 22.3%€213,850▼ 38.2%€146,726▼ 31.4%
Working capital€1.1mabove the sector's middle half€297,158within the sector's middle half▼ 73.9%€344,313within the sector's middle half▲ 15.9%€337,649within the sector's middle half▼ 1.9%€221,716within the sector's middle half▼ 34.3%
Solvency75.8%within the sector's middle half▲ 70.0pp39.7%within the sector's middle half▼ 36.1pp28.6%below the sector's middle half▼ 11.1pp36.8%within the sector's middle half▲ 8.2pp39.7%within the sector's middle half▲ 2.9pp
Current ratio4.16within the sector's middle half▲ 3.352.73within the sector's middle half▼ 1.433.46within the sector's middle half▲ 0.7311.29above the sector's middle half
Return on assets (ROA)-169.8%below the sector's middle half▼ 137.3pp-612.6%below the sector's middle half▼ 442.8pp-9.9%below the sector's middle half▲ 602.7pp-4.1%below the sector's middle half▲ 5.9pp-11.5%below the sector's middle half▼ 7.4pp
Staff (FTE)5.3within the sector's middle half▲ 76.7%5.6within the sector's middle half▲ 5.7%
above within below the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
-€6.0m-€4.0m-€2.0m€0Operating result 2020: -€4.6m-€4.6mNet result 2020: -€4.5m-€4.5mOperating result 2021: -€2.9m-€2.9mNet result 2021: -€2.9m-€2.9mOperating result 2022: -€46,985-€46,985Net result 2022: -€47,942-€47,942Operating result 2023: -€6,397-€6,397Net result 2023: -€13,718-€13,718Operating result 2024: -€20,722-€20,722Net result 2024: -€27,977-€27,97720202021202220232024-€60,000-€40,000-€20,000€0Operating result 2022: -€46,985-€47,000Net result 2022: -€47,942-€47,900Operating result 2023: -€6,397-€6,400Net result 2023: -€13,718-€13,700Operating result 2024: -€20,722-€20,700Net result 2024: -€27,977-€28,000202220232024
The operating result stays negative: a loss of €20,722 in 2024 against €6,397 in 2023; the loss grows.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Equity and liabilities €243,269
Equity €96,543 ▼ 22.5%
Debt €146,726 ▼ 31.4%
Debt's share of the balance-sheet total falls from 63.2% to 60.3%. Equity and debt are lower.
Key figures and ratios
2024 value · change against 2023
Debt to equity
1.52▼
2023 · 1.72
ROE
-29.0%▼
2023 · -11.0%
Debt ≤ 1 year
€21,553▲
2023 · €720
Debt > 1 year
€119,057▼
2023 · €207,433
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 4,805 companies that looked in July 2024 the way this one looks now, 2.0% went bankrupt within 24 months and 88% are still going.

  • Micro
  • 10 to 20 years old
  • solvency 30% or more
  • a loss of 10% of the balance sheet or more
2.0% went bankrupt
9.8% stopped otherwise
88% still going

A further 0.1% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a bankruptcy probability of 0.4% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,340 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 4,805 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2024 against 2023 · 31 lines
Balance sheet Code20232024
Assets
Total assets20/58€338,369€243,269▼
Current assets29/58€338,369€243,269▼
Amounts receivable after more than one year29€243,066€61,277▼
Other amounts receivable291€243,066€61,277▼
Amounts receivable within one year40/41€69,500€99,216▲
Other amounts receivable41€69,500€99,216▲
Cash at bank and in hand54/58€25,804€82,776▲
Equity and liabilities
Total equity and liabilities10/49€338,369€243,269▼
Equity10/15€124,520€96,543▼
Contributions10/11€7.6m€7.6m=
Capital10€7.0m€7.0m=
Issued capital100€7.0m€7.0m=
Outside capital11€583,665€583,665=
Share premium1100/10€583,665€583,665=
Profit (loss) carried forward14-€7.4m-€7.5m▼
Amounts payable17/49€213,850€146,726▼
Amounts payable after more than one year17€207,433€119,057▼
Other amounts payable178/9€207,433€119,057▼
Amounts payable within one year42/48€720€21,553▲
Trade debts44€720€21,553▲
Suppliers440/4€720€21,553▲
Accrued charges and deferred income492/3€5,696€6,116▲
Income statement Code20232024
Gross operating margin9900-€6,397-€20,722▼
Operating profit (loss)9901-€6,397-€20,722▼
Financial charges65/66B€7,321€7,255▼
Recurring financial charges65€7,321€7,255▼
Profit (loss) for the period before taxes9903-€13,718-€27,977▼
Profit (loss) for the period9904-€13,718-€27,977▼
Profit (loss) for the period to be appropriated9905-€13,718-€27,977▼
Appropriation of the result
Profit (loss) to be appropriated9906-€7.4m-€7.5m▼
Profit (loss) brought forward from the previous period14P-€7.4m-€7.4m▼

The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20202021202220232024Change
Remuneration, social security and pensions62-€510,394€327---
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€2.9m€1.8m----
Other operating charges640/8-€6,097€52---
Non-recurring operating charges66A-€1.1m----
Gross operating margin9900€944,413€536,501-€46,606-€6,397-€20,722▼ 224%
Operating profit (loss)9901-€4.6m-€2.9m-€46,985-€6,397-€20,722▼ 224%
Financial income75/76B-€571----
Recurring financial income75€2,006€571----
Financial charges65/66B-€8,976€957€7,321€7,255▼ 0.9%
Recurring financial charges65€11,947€8,976€957€7,321€7,255▼ 0.9%
Profit (loss) for the period before taxes9903-€4.6m-€2.9m-€47,942-€13,718-€27,977▼ 104%
Income taxes67/77-€99,180-€61,277----
Profit (loss) for the period9904-€4.5m-€2.9m-€47,942-€13,718-€27,977▼ 104%
Profit (loss) for the period to be appropriated9905-€4.5m-€2.9m-€47,942-€13,718-€27,977▼ 104%
Line20202021202220232024Change
Assets
Total assets20/58€2.7m€468,931€484,062€338,369€243,269▼ 28.1%
Fixed assets21/28€1.2m€248----
Intangible fixed assets21€1.1m-----
Tangible fixed assets22/27€31,508€248----
Furniture and vehicles24-€248----
Current assets29/58€1.5m€468,684€484,062€338,369€243,269▼ 28.1%
Amounts receivable after more than one year29-€353,925€312,523€243,066€61,277▼ 74.8%
Other amounts receivable291-€353,925€312,523€243,066€61,277▼ 74.8%
Amounts receivable within one year40/41€462,715€103,817€35,432€69,500€99,216▲ 42.8%
Trade receivables40-€34,557€34,706---
Other amounts receivable41-€69,259€726€69,500€99,216▲ 42.8%
Cash at bank and in hand54/58€585,293€8,402€136,107€25,804€82,776▲ 221%
Deferred charges and accrued income490/1-€2,540----
Equity and liabilities
Total equity and liabilities10/49€2.7m€468,931€484,062€338,369€243,269▼ 28.1%
Equity10/15€2.0m€186,180€138,237€124,520€96,543▼ 22.5%
Contributions10/11€6.0m€7.6m€7.6m€7.6m€7.6m=
Capital10-€7.0m€7.0m€7.0m€7.0m=
Issued capital100-€7.0m€7.0m€7.0m€7.0m=
Outside capital11-€583,665€583,665€583,665€583,665=
Share premium1100/10-€583,665€583,665€583,665€583,665=
Profit (loss) carried forward14-€4.5m-€7.4m-€7.4m-€7.4m-€7.5m▼ 0.4%
Amounts payable17/49€642,398€282,752€345,825€213,850€146,726▼ 31.4%
Amounts payable after more than one year17-€100,000€200,380€207,433€119,057▼ 42.6%
Other amounts payable178/9-€100,000€200,380€207,433€119,057▼ 42.6%
Amounts payable within one year42/48€360,349€171,526€139,749€720€21,553▲ 2,892%
Trade debts44€291,054€171,526€139,749€720€21,553▲ 2,892%
Suppliers440/4-€171,526€139,749€720€21,553▲ 2,892%
Accrued charges and deferred income492/3-€11,226€5,696€5,696€6,116▲ 7.4%
Line20202021202220232024Change
Profit (loss) for the period9904-€4.5m-€2.9m-€47,942-€13,718-€27,977▼ 104%
+ Depreciation and write-downs630€2.9m€1.8m----
Operating cash flow (approximation)-€1.6m-€1.1m-€47,942-€13,718-€27,977▼ 104%
Investment in fixed assets (approximation)--€656,053----
Change in cash--€576,891€127,705-€110,303€56,972▲ 152%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

2026
04-09
State Gazette act Resignation: Vizelu (director)
Appointments: PricewaterhouseCoopers Bedrijfsrevisoren (statutory auditor) and TROESCH Jonas (director) · Registered-office move · Director discharge6 facts ▸
  • General meeting, 18-08-2026
  • Registered-office move, Brussels Gewest, 1000 Brussel, Werkhuizenkaai 160
  • Director resignation, Vizelu (director)
  • Director discharge, Vizelu (director)
  • Auditor appointment, PricewaterhouseCoopers Bedrijfsrevisoren (statutory auditor)
  • Director appointment, TROESCH Jonas (director)
30-03
KBO administration Address struck
event 15-03-2026
2025
27-06
NBB filing Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
18-06
NBB filing Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
31-12
Financial Liquidity times 136current ratio 469.67
Current ratio from 3.46 to 469.67; short-term debt falls from €139,749 to €720.
18-08
NBB filing Annual accounts filed
fiscal year 2022 · abbreviated schema · 18 days late
2022
08-09
NBB filing Annual accounts filed
fiscal year 2021 · abbreviated schema · 39 days late
2021
30-09
NBB filing Annual accounts filed
fiscal year 2020 · abbreviated schema · 61 days late
2020
31-12
Financial Weakest financial yearnet -€4.5m
Net result drops to -€4.5m, the lowest in the series; recovery starts the following year.
31-12
Financial Liquidity times 5current ratio 4.16
Current ratio from 0.81 to 4.16; short-term debt falls from €2.2m to €360,349.
31-12
Financial Equity above €2mEq €2.0m ▲639%
Equity rises from €273,075 to €2.0m.
27-05
NBB filing Annual accounts filed
fiscal year 2019 · abbreviated schema
Show earlier events
2019
06-06
NBB filing Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
28-05
NBB filing Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
27-07
NBB filing Annual accounts filed
fiscal year 2016 · abbreviated schema
2016
22-06
NBB filing Annual accounts filed
fiscal year 2015 · full schema
SignalFinancial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
1 of 13 acts read
About the unread acts

Of the 13 Belgian State Gazette acts we know for this company, 1 has been read. The other 12 have not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
1 director, last change in 2026

Board 1

TROESCH Jonas
Director · since 02-03-2026
Current

Statutory auditor 1

PricewaterhouseCoopers Reviseurs d'Entreprises
Statutory auditor · since 04-09-2026 · perm. rep.: DELANOYE Didier
Current
Derived from published Gazette acts. The CBE keeps the official list of function holders; we do not read it, so the two can differ. See the function holders in the CBE →
Not every act has been read: a resignation may be missing here
12 of this company's 13 Belgian State Gazette acts have not been read yet. Appointments and resignations recorded in them are missing above: a director who resigned there may therefore still show here as sitting. The acts are in the Timeline.
Location & real-estate footprint
Registered office, Brussel · 1 establishment unit since 2017
seat establishment approximate The establishment unit on the map
Ground area
3.7 ha
Building footprint
48 m²
Volume, LiDAR
195 m³
Parcel 21813F0611/00L000, Brussels · tallest building 11.0 m, ±1 floor. Linked by address, not a title deed.
1 establishment unit
Oncurious
Werkhuizenkaai 160, 1000 BrusselHuman health activities
since 20172.265.755.791
1 parcel
Brussels 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
21813F0611/00L000 Brussels 3.7 ha 1 · 48 m² 11.0 m · 1 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Mandate history

3 people since 2026, 2 in office
Show
  • Board
  • Statutory auditor
  • began earlier
Mandates per person, with start and end dates
Name Functions and periods
TROESCH Jonas
  • Director, from 02-03-2026 to date
PricewaterhouseCoopers Reviseurs d'Entreprises
  • Statutory auditor, from 04-09-2026 to date
Vizelu
  • Director, until 02-03-2026
See the board, name and seat on a given date →

Articles of association

Registered office clause
Power of attorney
One provision in the deed

Structure & network

Owners and holdings

1 owner

Chain of control

  1. Oxurion 100%
  2. Oncurious

Highest known parent: Oxurion. The sources do not say who stands above it.

Owners 1

Holdings 0

No holding stated in the accounts, acts or LEI register we read.

According to the annual accounts of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.

Connections & network

1 current director
Depth

The network starts from this company’s directors. Other companies they run appear here as nodes.

This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, scroll to zoom.

Public money · subsidies and aid

Flemish government

2022 · 1 entry · 988 EUR awarded · 988 EUR paid
Year Entries awardedpaid
2022 1 988 EUR988 EUR
Schemes
1 entry · 988 EUR · 988 EUR paid · Departement Werk en Sociale Economie

Similar companies · same sector, comparable size

Of 699 companies in sector 86910 we hold annual accounts for 522. 335 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPublic limited company
Founded03-04-2015
Fiscal year end31-12
Activities, NACEBEL 2025
86910Medical imaging and medical laboratories
Contact
Phone +3216751310
E-invoicing
Reachable via Peppol
Peppol ID 0208:0627952462
Also 9925:BE0627952462
Registered 17-12-2025

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 30 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.